Harald E. Vonkeman
Medisch Spectrum Twente
Internal medicineSurgeryComputerized adaptive testingLogistic regressionRandomized controlled trialPhysical therapyRheumatologyCohort studyArthritisRheumatoid arthritisDiscontinuationDiseaseGoutPopulationIn patientFamily medicineMedicineCohortGastroenterology
176Publications
25H-index
2,203Citations
Publications 164
Newest
#1Caroline B. Terwee (PHRI: Public Health Research Institute)H-Index: 24
#2Marloes ZuidgeestH-Index: 6
Last. Leo D. RoordaH-Index: 33
view all 6 authors...
BACKGROUND The International Consortium for Health Outcomes Measurement (ICHOM) develops condition-specific Standard Sets of outcomes to be measured in clinical practice for value-based healthcare evaluation. Standard Sets are developed by different working groups, which is inefficient and may lead to inconsistencies in selected PROs and PROMs. We aimed to identify common PROs across ICHOM Standard Sets and examined to what extend these PROs can be measured with a generic set of PROMs: the Patie...
Source
#1Esther Beckers (UM: Maastricht University)H-Index: 2
#2M. Been (UM: Maastricht University)H-Index: 3
Last. Astrid van Tubergen (UM: Maastricht University)H-Index: 32
view all 7 authors...
Objective null null To investigate concurrent validity and discrimination of the Disease Activity Psoriatic Arthritis score (DAPSA), Psoriatic Arthritis Disease Activity Score (PASDAS) and Ankylosing Spondylitis Disease Activity Score (ASDAS) in peripheral spondyloarthritis (pSpA) in clinical practice. null null Methods null null Data from a Dutch registry for SpA (SpA-Net) were used. Predefined hypotheses on concurrent validity of the composite measures with 15 other outcome measures of disease...
Source
Patient-reported outcomes (PROs) on adverse drug reactions (ADRs) are increasingly used in cohort event monitoring (CEM) to obtain a better understanding of patients’ real-world experience with dru...
Source
#1Esther Beckers (UM: Maastricht University)H-Index: 2
#2Annelies Boonen (UM: Maastricht University)H-Index: 68
Last. Astrid van Tubergen (UM: Maastricht University)H-Index: 32
view all 7 authors...
OBJECTIVES To evaluate the extent to which internationally agreed treat-to-target (T2T) recommendations were applied in clinical practice in patients with axial spondyloarthritis (axSpA). METHODS Data were used from a web-based patient registry for monitoring SpA in daily practice in the Netherlands (SpA-Net). The extent to which T2T was applied was evaluated through four indicators: the proportion of patients 1) with ≥1 Ankylosing Spondylitis Disease Activity Score (ASDAS) assessed during a 1-y...
1 CitationsSource
#1G. A. Versteeg (UT: University of Twente)H-Index: 2
#2Lmm Steunebrink (UT: University of Twente)
Last. Mafj Van De Laar (Medisch Spectrum Twente)
view all 6 authors...
Objective: To evaluate radiological damage and to explore characteristics associated with radiological progression in rheumatoid arthritis (RA) treated to the target of remission in a real-world setting.Method: Baseline to 6 year follow-up data were used from an observational early RA cohort. Radiographs of hands and feet at baseline, 6 months, and 1, 3, and 6 years were scored using the modified Sharp/van der Heijde score (SHS). The threshold for rapid radiological progression (RRP) after 6 mon...
Source
Source
Background: null Information on adverse drug reactions (ADRs) is generally clustered for all indications of a drug in the patient information leaflet. However, previous research has shown that participants of the Dutch Biologic Monitor (DBM) that use a biologic for their immune-mediated inflammatory disease (IMID) prefer to receive ADR information tailored to their own biologic an IMID (1). Currently, it is unclear whether the ADR profile of a specific biologic may differ between patients with d...
Source
Source
Source
Source